Table 3 |
|||
|
Predictors of case fatality among children with severe pneumonia, Mulago Hospital, Ugandaa |
|||
|
Variable |
RR (Unadjusted) 95% CI |
RR (adjusted)b 95% CI |
RR (adjusted)c 95% CI |
|
|
|||
|
Zinc adjunct therapy |
0.3 (0.1,0.8) |
0.3 (0.1, 0.97) |
0.2 (0.0, 1.1) |
|
WHZ |
|||
|
<-2SD |
0.29 (0.1, 0.6) |
0.3 (0.1, 0.8) |
0.3 (0.1, 0.7) |
|
Oxygen saturation |
|||
|
< 92% |
2.4 (1.1, 5.1) |
1.6 (0.6, 3.9) |
1.4 (0.6, 3.3) |
|
HIV status |
|||
|
Positive |
2.7 (1.1, 6.6) |
2.6 (1.0, 6.7) |
4.3 (1.4, 12.7) |
|
Age |
|||
|
6 to 12 |
1.0 (0.5, 2.0) |
||
|
13 to 24 |
0.1 (0.0, 1.1) |
||
|
Caretaker relationship to child |
|||
|
Other |
0.8 (0.2, 3.2) |
||
|
Blood culture positive |
1.8 (0.6, 6.0) |
||
|
Zinc adjunct therapy* HIV statusd |
5.5 (0.5, 58.3) |
||
|
|
|||
|
a CI, confidence interval b Only variables with a P-value less than 0.25 in the unadjusted analysis were included in this model. c Model includes variables with a P-value less than 0.25 and the interaction term for HIV status and Zinc d Cross-product (interaction) term for HIV status and zinc |
|||
|
Srinivasan et al. BMC Medicine 2012 10:14 doi:10.1186/1741-7015-10-14 |
|||
